Showing 1 - 10 results of 10 for search 'Roisin E O’Cearbhaill', query time: 0.04s
Refine Results
-
1
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox by Sara Moufarrij, Roisin E. O’Cearbhaill
Published 2023-12-01
Article -
2
-
3
Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia by Azael Freites-Martinez, Anastasia Navitski, Claire F. Friedman, Donald Chan, Shari Goldfarb, Mario E. Lacouture, Roisin E. O'Cearbhaill
Published 2022-12-01
Article -
4
Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer by Chrisann Kyi, Alexia Iasonos, Carol Aghajanian, Paul Sabbatini, Ekaterina Doubrovina, Sara Kravetz, David Spriggs, Richard J O'Reilly, Roisin E O’Cearbhaill
Published 2021-08-01
Article -
5
Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas by Fionnuala Crowley, Karen A. Cadoo, Sarah Chiang, Diana L. Mandelker, Raazi Bajwa, Alexia Iasonos, Qin C. Zhou, Kathryn M. Miller, Martee L. Hensley, Roisin E. O'Cearbhaill
Published 2022-04-01
Article -
6
-
7
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission by Roisin E. O’Cearbhaill, Govind Ragupathi, Jianglong Zhu, Qian Wan, Svetlana Mironov, Guangbin Yang, Maria K. Spassova, Alexia Iasonos, Sara Kravetz, Ouathek Ouerfelli, David R. Spriggs, Samuel J. Danishefsky, Paul J. Sabbatini
Published 2016-04-01
Article -
8
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis by Sushmita Gordhandas, Brooke A. Schlappe, Qin Zhou, Alexia Iasonos, Mario M. Leitao, Jr., Kay J. Park, Louise de Brot, Kaled M. Alektiar, Paul J. Sabbatini, Carol A. Aghajanian, Claire Friedman, Oliver Zivanovic, Roisin E O'Cearbhaill
Published 2022-10-01
Article -
9
Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission by Beryl L. Manning-Geist, Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn, Krysten Soldan, William P. Tew, Nicholas J. Sarlis, Dmitriy Zamarin, Sara Kravetz, Ilaria Laface, Teresa Rasalan-Ho, Jingjing Qi, Phillip Wong, Paul J. Sabbatini, Roisin E. O’Cearbhaill
Published 2023-02-01
Article -
10
Pattern of disease and response to pembrolizumab in recurrent cervical cancer by Kathryn M. Miller, Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu-Rustum, Carol Aghajanian, Vance Broach, Lora H. Ellenson, Pier Selenica, Elizabeth L. Jewell, Chrisann Kyi, Yuliya Lakhman, Jennifer J. Mueller, Roisin E. O'Cearbhaill, Kay J. Park, Yukio Sonoda, Dmitriy Zamarin, Britta Weigelt, Mario M. Leitao, Jr, Claire F. Friedman
Published 2021-08-01
Article